217 related articles for article (PubMed ID: 30906213)
1. Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells.
Zhou L; Li M; Yu X; Gao F; Li W
Int J Biol Sci; 2019; 15(4):826-837. PubMed ID: 30906213
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway.
Li W; Ma X; Li N; Liu H; Dong Q; Zhang J; Yang C; Liu Y; Liang Q; Zhang S; Xu C; Song W; Tan S; Rong P; Wang W
Exp Cell Res; 2016 Dec; 349(2):320-327. PubMed ID: 27829129
[TBL] [Abstract][Full Text] [Related]
3. Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.
Li W; Gao F; Ma X; Wang R; Dong X; Wang W
Oncotarget; 2017 May; 8(20):32586-32599. PubMed ID: 28427230
[TBL] [Abstract][Full Text] [Related]
4. Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis.
Liu W; Li W; Liu H; Yu X
Int J Biol Sci; 2019; 15(11):2497-2508. PubMed ID: 31595166
[TBL] [Abstract][Full Text] [Related]
5. Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway.
Zheng J; Son DJ; Gu SM; Woo JR; Ham YW; Lee HP; Kim WJ; Jung JK; Hong JT
Sci Rep; 2016 May; 6():26357. PubMed ID: 27198178
[TBL] [Abstract][Full Text] [Related]
6. Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis.
Liu W; Yu X; Zhou L; Li J; Li M; Li W; Gao F
Onco Targets Ther; 2020; 13():3209-3221. PubMed ID: 32368080
[TBL] [Abstract][Full Text] [Related]
7. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
9. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
Wang F; Mao Y; You Q; Hua D; Cai D
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
[TBL] [Abstract][Full Text] [Related]
10. TRAF6 Promoted Tumor Glycolysis in Non-Small-Cell Lung Cancer by Activating the Akt-HIF
Feng L; Feng S; Nie Z; Deng Y; Xuan Y; Chen X; Lu Y; Liang L; Chen Y
Biomed Res Int; 2021; 2021():3431245. PubMed ID: 34409101
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
12. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK
J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
14. Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells.
Gao X; Han H
J Cell Biochem; 2018 Jun; 119(6):4967-4974. PubMed ID: 29384225
[TBL] [Abstract][Full Text] [Related]
15. miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2.
Jia KG; Feng G; Tong YS; Tao GZ; Xu L
J Biochem; 2020 Apr; 167(4):365-370. PubMed ID: 31742336
[TBL] [Abstract][Full Text] [Related]
16. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
[TBL] [Abstract][Full Text] [Related]
17. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
18. Ligustilide inhibits the proliferation of non-small cell lung cancer via glycolytic metabolism.
Jiang X; Zhao W; Zhu F; Wu H; Ding X; Bai J; Zhang X; Qian M
Toxicol Appl Pharmacol; 2021 Jan; 410():115336. PubMed ID: 33212065
[TBL] [Abstract][Full Text] [Related]
19. Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway.
Xu F; Gu J; Lu C; Mao W; Wang L; Zhu Q; Liu Z; Chu Y; Liu R; Ge D
Int J Biol Sci; 2019; 15(1):127-137. PubMed ID: 30662353
[TBL] [Abstract][Full Text] [Related]
20. Piperlongumine analogue L50377 induces pyroptosis via ROS mediated NF-κB suppression in non-small-cell lung cancer.
Li Q; Chen L; Dong Z; Zhao Y; Deng H; Wu J; Wu X; Li W
Chem Biol Interact; 2019 Nov; 313():108820. PubMed ID: 31518571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
